Clinical Trials Browser

Phase 1/2 × defactinib × 90 days × Clear all

NCT06630260 2026-01-21

5G-RUBY

Phase 1/2 Recruiting

Glioblastoma

NCT05074810 2026-01-12

RAMP203

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung